Health Canada Issues Recall of Apotex`s APO-AMITRIPTYLINE 10mg: NDMA Impurity
07 Feb 2023 //
HEALTH CANADA
Health Canada Issues Recall of AA Pharma`s Amitriptyline antidepressant drugs
07 Feb 2023 //
HEALTH CANADA
AlgoTx begins Phase II trial of neuropathy pain relief treatment
02 Sep 2022 //
CLINICALTRIALSARENA
Algo Announces Initiation of Global Phase 2 Clinical Trial of ATX01
01 Sep 2022 //
BUSINESSWIRE
Enforcement Report - Week of February 28, 2018
28 Feb 2018 //
FDA
FDA calls Truxton phenobarb, amitriptyline recalls Class I, II
23 Aug 2017 //
FIERCE PHARMA
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine
08 Nov 2016 //
PHARMA EXCIPIENTS
Rusan Pharma Ltd fails EDQM Inspection
04 Apr 2016 //
EDQM